Category Archives: Actos

Featured Stories
J.J. Fuds, Inc. Pet Food Recalled - Listeria Contamination

J.J. Fuds, Inc. Pet Food Recalled Over Potential Listeria Contamination

J.J. Fuds, has recalled a specific lot of its J.J. Fuds Chicken Tender Chunks Pet Food over potential contamination with the dangerous, Listeria monocytogenes pathogen.

Read More

Boston Scientific Transvaginal Mesh

Tennessee Woman Alleges Boston Scientific Transvaginal Mesh Product Caused Painful Injuries

More reports of painful injuries are being linked to transvaginal mesh. This time, a Tennessee woman has filed a lawsuit against Boston Scientific over its Advantage Transvaginal Mid-Urethral Sling System.

Read More

Decision on Pradaxa Bleeding Lawsuit Multidistrict Litigation Expected Soon

Victims of alleged Pradaxa injuries are awaiting word on whether their lawsuits will be consolidated in a multidistrict litigation. According to a report from The Madison Record, so far just over two dozen Pradaxa bleeding lawsuits have been filed in federal courts throughout the U.S.

Read More

Exploding Tanks Kill Jeep Drivers 18 months after Recall

Exploding Gas Tanks Continue to Kill Jeep Drivers 18 months after Recall

Chrysler recalled Jeeps with exploding gas tanks more than 18 months ago, but 1 million+ of these vehicles have not been fixed as the death toll continues to rise.

Read More

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

Two Men Found Dead of Carbon Monoxide Poisoning

Two Men Found Dead of Carbon Monoxide Poisoning at Long Island, New York Auto Shop

Two men were found dead of apparent carbon monoxide poisoning in a Holbrook, New York, auto-detailing shop Thursday night, Suffolk County police say.

Read More

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

EMA Seeks Stronger Pradaxa Guidance for Bleeding Side Effects

Regulators in Europe have again asked Boehringer Ingelheim, the manufacturer of the blood thinner Pradaxa, to update the drug’s label with additional information regarding Pradaxa bleeding side effects. According to the European Medicines Agency (EMA), the new guidance should include more specific information on when Pradaxa must not be used, ...

Read More

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

The U.S. Food & Drug Administration (FDA) is reviewing a new study that reported an increased risk of sudden, heart-related deaths among people using the antibiotic Zithromax (azithromycin), known popularly as Z-Pak. In a statement issued late yesterday, the FDA said patients being treated with Zithromax should not stop taking ...

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Controversial Diabetes Drug Actos Still on the Market

Controversial Diabetes Drug Actos Still on the Market

Though research has shown an association between the type 2 diabetes drug Actos and serious side effects including bladder cancer, heart failure, liver failure, and bone fractures, the Food and Drug Administration (FDA) has stopped short of recalling Actos. Actos … Continue reading

Posted in Actos, Pharmaceuticals | Tagged , , , , |

Actos Makers Continue to Face Bladder Cancer Claims

Actos Makers Continue to Face Bladder Cancer Claims

Lawsuits continue to be filed over Actos, a type 2 diabetes drug developed by Takeda and Eli Lilly. Plaintiffs in the litigation allege that Actos contributed to bladder cancer. Drug makers are accused of failing to disclose this risk to … Continue reading

Posted in Actos, Pharmaceuticals | Tagged , , , , |

Actos Bladder Cancer Cases Continue to be Filed

In the continuing controversy over the link between the type 2 diabetes drug Actos (pioglitazone) and bladder cancer, a new lawsuit was filed in June 2016 by a man who was diagnosed with bladder cancer after taking Actos for six … Continue reading

Posted in Actos, Defective Products, Health Concerns, Pharmaceuticals |

Diabetes Drug Pioglitazone Linked to Increased Risk of Bladder Cancer

An increased risk of bladder cancer has been uncovered following a large population-based study concerning patients who take the diabetes drug pioglitazone known to most as Actos, the Renal and Urology News reports. Pioglitazone is a single-ingredient product sold under … Continue reading

Posted in Actos, Health Concerns, Pharmaceuticals |

$2.4 Billion Settlement Announced in Actos Bladder Cancer Cases

$2.4B Settlement Announced in Actos Bladder Cancer Cases

On Tuesday, Takeda Pharmaceuticals announced a settlement that could go as high as $2.7 billion to resolve thousands of lawsuits from patients and their families who claim the diabetes drug Actos (pioglitazone) caused their bladder cancer. The New York Times … Continue reading

Posted in Actos, Health Concerns, Legal News, Pharmaceuticals | Tagged , , , |

Jury Awards $2 Million in Actos Case

Late last week, a Pennsylvania jury ordered Takeda Pharmaceuticals to pay more than $2 million to a woman who claimed her bladder cancer was caused by the company’s diabetes drug Actos (pioglitazone). The jury found that Takeda officials failed to … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

Actos Litigation Update: Takeda Pharmaceutical Company, Eli Lilly and Company Ordered to Pay $9 Billion in Punitive Damages

Takeda Pharmaceutical Company and Eli Lilly and Company were just ordered to pay a total of $9 billion in punitive damages over Actos litigation involving bladder cancer allegations. Takeda and Eli Lilly lost a bid to have the Actos trial … Continue reading

Posted in Actos, Pharmaceuticals |

Jury Deliberations Begin in Nevada Actos Trial

On Tuesday, a jury in the Las Vegas began deliberating to determine whether Takeda Pharmaceuticals is liable for the bladder cancer of two women, both in their 80s, who were diagnosed with the disease after taking the diabetes drug Actos … Continue reading

Posted in Actos, Health Concerns, Legal News, Pharmaceuticals |

Judge May Punish Lawyers for Misconduct in Actos Trial

Las Vegas district judge Kerry Earley is considering a request to punish lawyers for misconduct during a civil trial over the cancer risks associated with Takeda Pharmaceuticals’ diabetes drug Actos. On Thursday, Judge Earley heard arguments from an attorney representing … Continue reading

Posted in Actos, Health Concerns, Legal News, Pharmaceuticals |

Takeda May Not Pay Eli Lilly’s Portion of Actos Injury Lawsuit

Eli Lilly & Co. has indicated that its former marketing partner, Takeda Pharmaceutical Co., may not pay Lilly’s share of a recent United States jury verdict that ordered Takeda and Lilly to pay $9 billion in punitive damages in a … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.